Physician profile
Howard J Prusack
NPI 1598744161
$792.29
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2022: $479 · 2023: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $219.10 | 2022 | |
| Medtronic, INC. | $163.06 | 2023 | Intellis Adaptivestim |
| Sunovion Pharmaceuticals INC. | $116.75 | 2019 | |
| Redhill Biopharma INC. | $55.06 | 2022 | |
| Ironwood Pharmaceuticals, INC | $45.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.65 | 2022 | |
| Vivus LLC | $29.99 | 2022 | |
| Qol Medical, LLC | $23.89 | 2022 | |
| Braintree Laboratories, INC. | $20.16 | 2022 | |
| Endo Pharmaceuticals INC. | $17.93 | 2023 | Xiaflex |
| Daiichi Sankyo INC. | $17.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.03 | 2022 | |
| Coopersurgical, INC. | $15.48 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Merck Sharp & Dohme LLC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Prusack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.